Triethylamine → 7-Furan-2-yl-2-[4-(5-methyl-isoxazol-3-ylmethyl)-[1,4]diazepan-1-yl]-pyrazolo[1,5-a][1,3,5]triazin-4-ylamine
Reaction equation
Cl[CH2:2][C:3]1[CH:7]=[C:6]([CH3:8])[O:5][N:4]=1.[N:9]1([C:16]2[N:21]=[C:20]([NH2:22])[N:19]3[N:23]=[C:24]([C:26]4[O:27][CH:28]=[CH:29][CH:30]=4)[CH:25]=[C:18]3[N:17]=2)[CH2:15][CH2:14][CH2:13][NH:12][CH2:11][CH2:10]1.CCN(CC)CC>CC#N>[O:27]1[CH:28]=[CH:29][CH:30]=[C:26]1[C:24]1[CH:25]=[C:18]2[N:17]=[C:16]([N:9]3[CH2:15][CH2:14][CH2:13][N:12]([CH2:2][C:3]4[CH:7]=[C:6]([CH3:8])[O:5][N:4]=4)[CH2:11][CH2:10]3)[N:21]=[C:20]([NH2:22])[N:19]2[N:23]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
3-Chloromethyl-5-methyl-isoxazole (1.5 eq.) was directly added to a solution of 2-[1,4]diazepan-1-yl-7-furan-2-yl-pyrazolo[1,5-a][1,3,5]triazin-4-ylamine (0.14 mmol) and Et3N (0.3 mmol) in 3 mL of CH3CN. The resulting reaction mixture was stirred at room temp for 18 hours. It was then concentrated and purified by preparative HPLC using a mixture of aqueous CH3CN that has been buffered with 0.1% TFA. 1H NMR (DMSO-d6) δ 7.90 (br s, 2 H), 7.80 (d, J=1.0 Hz, 1H), 7.05 (d, J=3.6 Hz, 1H), 6.68 (dd, J=3.6 Hz, 1.0 Hz, 1H), 6.30 (s, 1H), 3.65 (m, 2H), 3.20-2.75 (m, 10 H), 2.35 (s, 3H) ppm. MS: m/z: 395 [M+H]+.
Workup
- customThe resulting reaction mixture
- concentrationIt was then concentrated
- custompurified by preparative HPLC
- additiona mixture of aqueous CH3CN that
Sources & evidence
- ORD record
- ord-a7f1f2883d5e4ca8a0c4b22831125230
- Source dataset
- uspto-grants-2007_10
- Patent number
- US07285550B2
Reaction notes
Loading…